chrisvoncsefalvay/vaers-outcomes huggingface dataset:
blood in urine 10 days after vaccination.; This is a spontaneous report received from a contactable consumer, the patient. A 75-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 12:30 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. Medical history included left nephrectomy in 2010, irritable bowel syndrome (IBS). Concomitant medications included thyroid (ARMOUR THYROID) and tamsulosin hydrochloride (FLOMAX); both from an unknown date and an unspecified indication. The patient was a known allergic to opiates and lactose. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 17:30, the patient experienced blood in urine ten days after vaccination. The event resulted in doctor or other healthcare professional office or clinic visit. The patient received antibiotics as treatment for the event blood in urine. The clinical outcome of the event blood in urine was recovering.   No follow-up attempts are possible; information about lot number cannot be obtained.
Sharp pins and needles feeling in the palm  and fingers of left hand. Numbness of left hand/figerpad. +Paresthesias.
This spontaneous report as received from an Immunization Program refers to a patient of unknown age. On an unknown date the patient was vaccinated with a dose of improperly stored PNEUMOVAX23 (lot # H010515, expiration date 13-FEB-2014) (dose and route not reported). Additional information is not expected.
She got her 4th vaccine, didn't have any problems until about 10:00 PM the following day.  The injection site started to itch and hurt, and now has a lump in her arm, which is still there and hurting.  She is taking Benadryl for it and hydrocortisone on the area.  The lump is about the size of a quarter.  She contacted her doctor and he told her to take the Benadryl and cream.  She had no problems with the other 3 vaccines.  He feels it is a subcutaneous reaction to the vaccine.   He informed her that if it did not get any better to come in and see him.  It has not gotten any better and not any worse, and told her to call us and report it to us as she has numerous allergies.
This spontaneous report as received from a registered nurse refers to a 14 year old male patient. On 01-JUL-2014, the patient was vaccinated with the first dose (Oka/Merck) VARIVAX lot # J012376, expiration date 03-OCT-2015, 0.5 ml, subcutaneous. On 12-AUG-2014, the patient was vaccinated with the second dose of (Oka/Merck) VARIVAX (lot # and expiration date were not reported), 0.5 ml, subcutaneous. On 22-SEP-2014, the patient was mistakenly vaccinated with the third dose of (Oka/Merck) VARIVAX lot # J013728, expiration date 30-OCT-2015, subcutaneous. No adverse effects were reported. Additional information has been requested.
Initial overdose report received from a healthcare professional on 10 May 2013. It was reported that ActHIB and PENTACEL both were administered on the same day (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
Child developed rash on chest, face, thighs, back upper arms. Non-pruritic. No kaplicks spots, petechia, no fever.
Swelling of eyes, chest pain, dizzy, developed heart problems after the vaccine. Couldn't hardly breathe, walk.
Over heating; Headache/Bursting pain in left side of head; Body aches; Hot flushes/Little bit different than normal ones,come fast and go fast.; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Hot flushes/Little bit different than normal ones,come fast and go fast.), HYPERTHERMIA (Over heating), HEADACHE (Headache/Bursting pain in left side of head) and MYALGIA (Body aches) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A and 041B21A) for COVID-19 vaccination.     Concomitant products included THYROID (ARMOUR THYROID) for Thyroid disorder.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced HOT FLUSH (Hot flushes/Little bit different than normal ones,come fast and go fast.). On an unknown date, the patient experienced HYPERTHERMIA (Over heating), HEADACHE (Headache/Bursting pain in left side of head) and MYALGIA (Body aches). The patient was treated with IBUPROFEN for Headache, at an unspecified dose and frequency. At the time of the report, HOT FLUSH (Hot flushes/Little bit different than normal ones,come fast and go fast.), HYPERTHERMIA (Over heating), HEADACHE (Headache/Bursting pain in left side of head) and MYALGIA (Body aches) outcome was unknown.
Started off getting very itchy, then hives developed, and I turned red, I became very hot...24 hours later I had flu like symptoms along with a blistering rash on my neck, face and scalp..with a few spots on my chest and back. These started to heal 5 days after injection, then started to resurface. On Day 3 I started getting short of breath and intermittent chest pains accompanied by a heart rate ranging from 110 to 126. I developed a severe headache and fatigue.
This spontaneous report as received from a pharmacist refers to a 66 years old female patient. The patient was vaccinated with expired PNEUMOVAX 23 (lot# 669776/0614AA; expired date 27-SEP-2012) 0.5 ml intramuscularly in left arm on 01-OCT-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse effects reported at this time. Additional information has been requested.
Pfizer-BioNTech Covid 19 Vaccine: Patient reports "indescribable" muscle pain beginning almost exactly 4 hours after vaccination which has persisted until time of this report (day 7).   She notes minimal pain at injection site.  Has had no fever, no nausea/vomiting/diarrhea.  She states that her entire body hurts, including hair, teeth, toenails, and fingernails - she describes as throbbing pain.  She also reports pain in back and thoracic muscles to the extent that she cannot bend down to put on shoes.  She notes that the back pain was not initially present but started around day 5 (12/22/20).  She describes this as muscle pain and does not have visceral pain.   She reports some relief with acetaminophen and ibuprofen.  She also describes alternating episodes of feeling "freezing cold" with shaking chills followed by profuse diaphoresis (describes sweat as pooling and dripping).  Acetaminophen and ibuprofen have not relieved or lessened the episodes of chills and sweats.
Pain in arm for over 72 hours, Passing out, paralysis, migraines, weakness, insomnia, chronic pain, chronic fatigue, motor tics, functional tics, vocal tics, racing heart, Postural Orthostatic Tachycardia Syndrome
As soon as the shot was administered I began to feel lightheaded. I felt a tingling sensation spread across my face and upper body and it took a lot of willpower to focus. This effect lasted strongly; I felt a tingling sensation spread across my face and upper body; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 02Apr2021 at 15:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Patient was allergic to food dyes and additives when younger. Concomitant medications included ethinlyestradiol; etonogestrel (NUVARING), vitamin d (MANUFACTURER UNKNOWN) and cetirizine hydrochloride (ZYRTEC) from unknown date and unspecified indication. Prior to vaccination, patient was not diagnosed with COVID-19. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 15:00, as soon as the shot was administered patient began to feel lightheaded and she felt a tingling sensation spread across her face and upper body and it took a lot of willpower to focus. This effect lasted strongly for 2 hours, and even by the end of the day she could feel residual effects. It was very similar to patient experienced donating platelets and her body response to the citrate. A physician friend thought it may be an anxiety response to needles, but patient stated that she had absolutely no fear of needles and had given blood many times without this effect. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lightheaded and tingling were recovered on 02Apr2021.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a mother refers to her 4 year old daughter. On 12-JUL-2013 the patient was vaccinated with M-M-R II (lot # H017437, expire date 20-SEP-2014). Other concomitant therapies included DAPTACEL. Concomitant therapies included NASONEX, VARIVAX, and IPOL. On 13-JUL-2013 the patient experienced a "2.5 to 3 inch, almost circular, swollen, red, very hard, hot and itchy area round the injection site of M-M-R II), on 07/13/2013. Patient also received VARIVAX (Merck),  DAPTACEL and IPOL. DAPTACEL was administered in the same arm as the M-M-R II and VARIVAX and IPOL were administered in the other arm; however, there were no injection site reactions to the other vaccines. The patient sought medial attention via called physician office. Mother contacted physician's office 07/13/2013, 07/14/2013 and 07/15/2013. Treatment was given by ice pack locally, ibuprofen, TYLENOL. At the time of the report, the event outcome was unknown. Additional information has been requested.
Pt received the bivalent Moderna vaccine yesterday but had pain worsening all night long since the injection. She was virtually seen by MD today & given benadryl & medrol dose pack.
Unauthorized age group.  Received first dose of Moderna vaccine.  Received vaccine on 07/27/2021.  Follow up phone call to parent on 07/28/2021. Patient had only c/o soreness at injection site and reported he had slept on the side the injection was given on.
High fever of 102 - 104.1 for 24 hours even with tylenol. Severe body chills and shaking, uncontrollable shaking , exessive sweating, severe body aches worst of my life.  I was tested back in late March 2021 for Covid and two seperate tests came back unconclusive. This is when there were not enough tests to go around and I was advised to quarentine. Based on the length and severity of my symtoms my Dr believes I actually had Covid and had false positive test, He has also said that his patients that have had Covid or a false-positive that their second dose has more severe side effects than for others that haven't. I was bedriddent for 2 days and am still recovering.
On 1/16/2020 the patient was noted to have erythema on her hand which she noted was pruritic. She noted additional swelling and discomfort and 2 days later area was raised, red/purple and noted as painful and itchy. She sought out help from a physician who noted the area as possible cellulitis and prescribed cephalexin. 2 days later the patient reported to Urgent Care noting more pain and worsening swelling at the site on her Right palm. It was also noted she had a swollen, red lesion on the Right side of her back adjacent to her right scapula.  The patient was diagnosed with shingles and was started on Valtrex.  Due to timeline and closeness to vaccination dose, consideration of an immune modulated reaction.
This spontaneous report was received from a 55  year old female patient regarding herself. The patient had no pertinent medical history. The patient has possibly penicillin allergy. On 28-JAN-2013, the patient was vaccinated with a dose of 0.65 ml live ZOSTAVAX, (lot number reported as 9989115 expiration date and route was not reported) under the skin. No concomitant medications were reported. On 28-JAN-2013, (reported as after 5 hours later) the patient experienced cold sore. On 29-JAN-2013(reported as today) she has a slight headache. Treatment rendered for the event cold sore was DENAVIR (topically one dose only). There were no lab diagnostics performed. At the time of this report the patient had not recovered from the events. The patient stated that she was prone to getting cold sores and headaches and does not think it was related to the live ZOSTAVAX. Additional information is not expected.
3 macular, pink-erythematous, areas on right deltoid. No itching. Mild warmth. Mild swelling underneath middle area in location of 2 injections.
acute pain; This case was reported by a other health professional via other manufacturer and described the occurrence of pain in a 45-year-old female patient who received HPV 16-18 (Cervarix) for prophylaxis.   On an unknown date, the patient received the 3rd dose of Cervarix. On an unknown date, unknown after receiving Cervarix, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Cervarix.  Additional details were provided as follows: The age at vaccination was not reported. The patient developed acute pain following a 3rd injection of Cervarix, the prophylactic human papillomavirus 16 per 18 vaccine.
While being observed in waiting area, patient reported that she felt as if she was going to pass out.  Patient was then lowered to the ground by 2 medics as patient briefly passed out.  Patient was taken to medic area where she informed that she often has syncopal episodes.
After first day patient had initial inject site reaction, redness and itching. Reaction resolved by day 4 and then returned again on day 7. Rash was a square red patch near injection site, patient reported itching and mild pain. Patient stated had a similar reaction a few years ago when she received zostavax.
Swollen lymph nodes in neck very painful, goes up through back of neck and lower head & into ears.  Have gone to primary dr, ear nose & throat dr, & dentist.  No one seems to have any answers. Had x-rays done & sonogram - all were negative but pain is continuing. only relief is 800 mg ibuprophen but relief is temporary. As soon as it wears off pain & swelling is back. Please help
1/4/2022 Here for cough, congestion,s/t, loss of voice. Started after christmas with symptoms and have gradually gotten worse. She was recently treated for a UTI with her gyn and is on macrobid. She has been on macrobid x 5 days.    She is 26 weeks pregnant.   H/o: hyperlipidemia, suppressed TSH (during pregnancy), elevated TPO, Hashimoto's thyroiditis. Her mother has h/o thyroid storm and hyper and hypothyroid also. Displaced distal coccyx per xray 10-2019. Has chronic coccyx pain from hypermobility and subluxation of her coccyx. 1/20/22 Hx COVID+ 1/4:  Rec baby ASA.  Had sore throat, thought it was Strep.   Serial growth.  Will get scheduled first available. -28wk labs/TDaP today.  1/20/22 Ob-Gyn visit  -Hashimoto's Thyroid:  Stable on no meds, followed by Endocrin  Will confirm date next visit.   -BMI 33 (30):  TWG 19. -Discussed KCs.  Knows labor precautions.  1/4/22  Review of Systems  Constitutional: Positive for chills. Negative for activity change, appetite change, diaphoresis, fatigue, fever and unexpected weight change.  HENT: Positive for congestion, postnasal drip, rhinorrhea and sore throat. Negative for dental problem, drooling, ear discharge, ear pain, facial swelling, hearing loss, mouth sores, nosebleeds, sinus pressure, sneezing, tinnitus, trouble swallowing and voice change.   Eyes: Negative for photophobia, pain, discharge, redness, itching and visual disturbance.  Respiratory: Positive for cough. Negative for apnea, choking, chest tightness, shortness of breath, wheezing and stridor.   Cardiovascular: Negative for chest pain, palpitations and leg swelling.  Gastrointestinal: Negative for abdominal distention, abdominal pain, anal bleeding, blood in stool, constipation, diarrhea, nausea, rectal pain and vomiting.  Endocrine: Negative for cold intolerance, heat intolerance, polydipsia, polyphagia and polyuria.  Genitourinary: Negative for decreased urine volume, difficulty urinating, dysuria, enuresis, flank pain, frequency, genital sores, hematuria and urgency.  Musculoskeletal: Negative for arthralgias, back pain, gait problem, joint swelling, myalgias, neck pain and neck stiffness.  Skin: Negative for color change, pallor, rash and wound.  Allergic/Immunologic: Negative for environmental allergies, food allergies and immunocompromised state.  Neurological: Negative for dizziness, tremors, seizures, syncope, facial asymmetry, speech difficulty, weakness, light-headedness, numbness and headaches.  Hematological: Negative for adenopathy. Does not bruise/bleed easily.  Psychiatric/Behavioral: Negative for agitation, behavioral problems, confusion, decreased concentration, dysphoric mood, hallucinations, self-injury, sleep disturbance and suicidal ideas. The patient is not nervous/anxious and is not hyperactive.
Both him and wife reported infections after the shots. Went to a walk in clinic two days later. Reported this to coroporate.
arm was sore; arm swelled; their is a lump; This is a spontaneous report from a from a Pfizer Sponsored Program COVAX US Support. A contactable female of an unspecified age reported for herself that she received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), second dose via an unspecified route of administration on 18Mar2021 single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), first dose via an unspecified route of administration on unspecified date of 2021 single for covid-19 immunization. On unspecified date of Mar2021 the patient experienced her arm swelled and was sore. She was told to put ice on it and did that but it is not working and now there was a lump. She wanted to know if the lump will go away and her arm was still sore. The outcome of the event arm was sore was unknown. While outcome of the rest of the events was not recovered.     No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
no additional AE/PQC was reported at time of call; 6 month old patient has received 3 doses of PEDVAXHIB at 2 months, 4 months and 6 months of age; This spontaneous report was received from a pharmacist and refers to a 6-month-old patient of unknown gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On an unknown date in July 2021 (reported as at 2 months of age), the patient was vaccinated with the first dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), 0.5 mL, for prophylaxis (route of administration, anatomical location, lot # and expiration date were not provided).  On an unknown date in September 2021 (reported as at 4 months of age), the patient was vaccinated with the second dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), 0.5 mL, for prophylaxis (route of administration, anatomical location, lot # and expiration date were not provided).  On an unknown date in November 2021 (reported as at 6 months of age), the patient was vaccinated with the third dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), 0.5 mL, for prophylaxis (route of administration, anatomical location, lot # and expiration date were not provided) (inappropriate schedule of product administration).  It was noted that recommendations for three-dose series for patients aged 2-10 months at first dose, according to the product prescribing information, is 2 doses, 2 months apart and a booster at age 12-15 months. No additional information was provided. The reporter stated "it occurred at one of the clinics". No additional adverse event (AE) / product quality complaint (PQC) was reported at time of call.
After vaccine booster shot injection, patient was helping to pull down long sleeve shirt, however having difficulty. RN vaccine administrator assisted, and when fingers brushed over the sleeves in the right upper arm and felt it was getting slightly swollen. RN proceeded to check vaccination location/ site of injection, and a small 10mm bump was felt. Not warm to the touch, only slight generalized swelling around the bump. Asked the patient to stay for extra 30mins for observation. Vitals taken: BP 142/82mmHg , Pulse 96 bts/min, O2 97%, Temperature 37C. Patient states feels fine, no complaints. Will continue to monitor.
Severe hair loss (bold on top of head); This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Severe hair loss (bold on top of head)) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ALOPECIA (Severe hair loss (bold on top of head)). The patient was treated with MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) at a dose of 1 dosage form. At the time of the report, ALOPECIA (Severe hair loss (bold on top of head)) outcome was unknown. Not Provided          The action taken with mRNA-1273 with the events was considered as not applicable No concomitant medications was provided.    Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: NNI, email or fax number requested from consumer, consumer declined to share email address
Itchy red rash about the size of a half dollar on underside of inner left elbow.
Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Medium, Systemic: Tachycardia-Mild, Additional Details: Had a panic attack
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 67-year-old female patient who received SHINGRIX (batch number 2AH5M, expiry date 21st May 2021) for prophylaxis. On 14th January 2019, the patient received the 1st dose of SHINGRIX. On 15th January 2019, 1 days after receiving SHINGRIX, the patient experienced injection site erythema, injection site swelling, rash and hives. On an unknown date, the outcome of the injection site erythema, injection site swelling, rash and hives were unknown. It was unknown if the reporter considered the injection site erythema, injection site swelling, rash and hives to be related to SHINGRIX. Additional details were provided as follows: Approximately 24 hours after receiving the vaccine, the patient experienced redness and swelling at the injection site. The patient, also had hives and rash on back of legs, back, and chest. The reporter consented to follow up.